We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 731

Court of Appeal Dismisses Appeal for Different Reasons and Provides Review of the Obvious to Try Test
  • Borden Ladner Gervais LLP
  • Canada
  • April 19 2017

The Court of Appeal dismissed Bristol-Myers Squibb's appeal from the Trial Judge's decision refusing its application for a writ of prohibition on the


Court of Appeal Grants Appeal as it Relates to Duty to Mitigate
  • Borden Ladner Gervais LLP
  • Canada
  • April 19 2017

In this decision, the Court of Appeal was considering an appeal by Apotex of various findings of the Court relating to its action seeking damages from


Apotex Granted Leave to Expand Scope of Evidence Available to Prove its NIA Plea
  • Borden Ladner Gervais LLP
  • Canada
  • April 12 2017

In this recently reported decision, the Court granted Apotex leave to deliver Fresh as Amended Responding Statement of Issues for the reference into


Statutory Damages Awarded in Copyright Infringement Case
  • Borden Ladner Gervais LLP
  • Canada
  • April 12 2017

Through its websites "autotrader.ca" and "autohebdo.net", Trader operates "digital Marketplaces" relating to new and used vehicles in Canada. Trader


ONCA upholds Summary Judgment Concerning Dispute over Website Domain Names
  • Borden Ladner Gervais LLP
  • Canada
  • April 12 2017

The Ontario Court of Appeal (ONCA) dismissed the Appellant's appeal from a summary judgment dismissing its action and from an order dismissing the


Court dismisses JR of Minister's decision requiring additional information for approval of certain products manufactured or tested at two of Apotex's manufacturing facilities
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2017

The Court dismissed Apotex's application for judicial review, finding that Therapeutic Products Directorate of Health Canada's ("TPD") decision


Order of prohibition dismissed in respect of two patents listed against dasatinib
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2017

The Court dismissed Bristol Myers Squibb's application for an order prohibiting the Minister from issuing an NOC to Apotex for its generic version of


Court provides method for assessing quantum of Teva's section 8 damages
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2017

In this case, the parties had asked the Court for specific rulings and guidance in calculating Teva's section 8 damages. The parties were in agreement


Appeal of the Trademark Opposition Board's decision rejecting opposition to HONEY MOMENTS allowed
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2017

The Court allowed an appeal of the Trademark Opposition Board's decision rejecting Ms. McDowell's opposition to the registration of the HONEY MOMENTS


Opposition Board's decision refusing to register TASTE OF B.C. upheld on appeal
  • Borden Ladner Gervais LLP
  • Canada
  • March 29 2017

The Federal Court dismissed an appeal of the Trademarks Opposition Board's ("Board's") refusal to register the mark TASTE OF B.C. In the opposition